UAS Pharmaceuticals Pty

Company snapshot

UAS Pharmaceuticals Pty Ltd is a global Australian company dedicated to helping people achieve their best skin and hair through the power of natural ingredients and medical-grade formulas. UAS develops premium skin and hair care products across 4 brands: Neutriderm, Dermavive, Sunstop, and Dermqure. Our brands are designed to target and reach different individuals within a range of markets worldwi

• 4 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for UAS Pharmaceuticals Pty. Not investment advice.

• Peer + 0 momentum

  Incyte

  TA overlap score 30.6

• Peer + 0 momentum

  VYNE Therapeutics

  TA overlap score 26

• Peer + 0 momentum

  Dermata Therapeutics

  TA overlap score 20.8

Recent activity

Latest pipeline, patent, and corporate events for UAS Pharmaceuticals Pty.

1. May 26, 2026 Clinical update

   Adapalene 0.3% / BPO 2.5% gel — Phase 3

2. May 26, 2026 Clinical update

   Nemolizumab — Phase 3

3. May 26, 2026 Clinical update

   Nemolizumab — Phase 3

4. May 26, 2026 Clinical update

   Nemolizumab — Phase 2

View all clinical trial activity →

• What is UAS Pharmaceuticals Pty?

  Galderma Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Atopic Dermatitis, Acne Vulgaris, Prurigo Nodularis. NovaPharmaNews links 4 clinical program(s), 5 drug profile(s), and 0 patent record(s) to this entity from public FDA,

• Is UAS Pharmaceuticals Pty publicly traded?

  UAS Pharmaceuticals Pty appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does UAS Pharmaceuticals Pty develop or market?

  We link 7 drug profile(s) where UAS Pharmaceuticals Pty is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/galderma-international#company-drugs.

• What are the latest developments for UAS Pharmaceuticals Pty?

  In the last 12 months our linked public records show 4 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does UAS Pharmaceuticals Pty focus on?

  UAS Pharmaceuticals Pty focuses on Atopic Dermatitis, Acne Vulgaris, Prurigo Nodularis based on our analysis of their pipeline programs and drug development activities.